Medaksa - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 14,054 | 38,502 | 30,204 | 165,698 | 158,387 | 193,759 | 230,765 | 198,641 |
| Profit before tax | 4,781 | 11,468 | 4,502 | 1,088 | -1,446 | -14,454 | 3,818 | 4,952 |
| Net profit | 4,064 | 10,764 | 4,277 | 689 | -1,578 | -14,454 | 3,818 | 4,952 |
| Equity | 11,026 | 22,270 | 16,208 | 16,916 | 15,329 | 874 | 4,692 | 9,644 |
| Liabilities | 0 | - | - | - | 2,978 | 29,494 | 21,666 | 22,752 |
| Non-current assets | 8,421 | 6,271 | 4,121 | 6,684 | 2,694 | 591 | 3 | 773 |
| Current assets | 2,605 | 17,121 | 13,874 | 12,639 | 15,613 | 29,777 | 26,355 | 31,623 |
| Total assets | 11,026 | 23,392 | 17,995 | 19,323 | 18,307 | 30,368 | 26,358 | 32,396 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 26,119 | 35,386 | 29,548 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +49.9% | +174.0% | -21.6% | +448.6% | -4.4% | +22.3% | +19.1% | -13.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 36.9% | 46.0% | 23.8% | 3.6% | -8.6% | -47.6% | 14.5% | 15.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 36.9% | 48.3% | 26.4% | 4.1% | -10.3% | -1653.8% | 81.4% | 51.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 28.9% | 28.0% | 14.2% | 0.4% | -1.0% | -7.5% | 1.7% | 2.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 34.0% | 29.8% | 14.9% | 0.7% | -0.9% | -7.5% | 1.7% | 2.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.2 | 33.7 | 4.6 | 2.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 165,698 | 158,387 | 70,458 | 76,922 | 99,321 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medaksa - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-07-16 | 2024-07-16 | 143.76 |
| 2024-05-16 | 2024-05-16 | 242.31 |
| 2024-04-16 | 2024-04-17 | 392.17 |
Medaksa - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-08 | 2026-03-11 | 1853.97 |
| 2026-03-02 | 2026-03-07 | 1851.57 |
| 2026-01-29 | 2026-02-16 | 4.13 |
| 2026-01-01 | 2026-01-01 | 0.02 |
| 2025-09-26 | 2025-09-26 | 6.93 |
| 2025-09-25 | 2025-09-25 | 218.4 |
| 2025-06-10 | 2025-06-26 | 3.84 |
| 2025-06-04 | 2025-06-09 | 3.9 |
| 2025-06-02 | 2025-06-03 | 2034.75 |
| 2025-05-29 | 2025-06-01 | 2032.55 |
| 2025-04-28 | 2025-04-28 | 15.07 |
| 2025-04-16 | 2025-04-27 | 0.07 |
| 2025-04-04 | 2025-04-15 | 3.26 |
| 2025-04-03 | 2025-04-03 | 3.15 |
| 2025-04-02 | 2025-04-02 | 755.76 |
| 2025-03-30 | 2025-04-01 | 1468.5 |
| 2025-03-05 | 2025-03-29 | 1.26 |
| 2025-03-04 | 2025-03-04 | 638.32 |
| 2025-03-02 | 2025-03-03 | 637.81 |
| 2025-02-28 | 2025-03-01 | 637.3 |
| 2025-02-20 | 2025-02-24 | 0.3 |
| 2025-02-07 | 2025-02-18 | 0.14 |
| 2025-01-30 | 2025-02-06 | 0.36 |
| 2025-01-01 | 2025-01-01 | 1564.92 |
| 2024-12-31 | 2024-12-31 | 1560.96 |
| 2024-12-30 | 2024-12-30 | 4360.97 |
| 2024-12-08 | 2024-12-12 | 2.75 |
| 2024-12-07 | 2024-12-07 | 5.53 |
| 2024-11-28 | 2024-12-06 | 2.7 |
| 2024-11-17 | 2024-11-27 | 2.17 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medaksa, MB (code 304222528) is a Small partnership engaged in retail sale of other medical and orthopaedic goods. In 2025, the company generated revenue of €198.6K, down 13.9% year on year, while still remaining slightly above the 2023 level, when revenue was €193.8K. Profitability improved materially over the three-year period: the company recorded a net loss of €14.5K in 2023, a net profit of €3.8K in 2024, and net profit of €5.0K in 2025. The 2025 profit margin was 2.5%, indicating modest profitability on the current revenue base. The balance sheet at the end of 2025 showed total assets of €32.4K, equity of €9.6K and liabilities of €22.8K. Equity represented 29.8% of assets, and liabilities were 2.36 times equity. Asset turnover was 6.13x, reflecting a relatively efficient use of assets. Revenue per employee was €99.3K, with profit per employee of €2.5K.